Old Web
English
Sign In
Acemap
>
Paper
>
The real world safety profile of ibrutinib in relapsed/refractory CLL/SLL patients in Japan
The real world safety profile of ibrutinib in relapsed/refractory CLL/SLL patients in Japan
2019
Hiroaki Fujimori
Keywords:
Oncology
Ibrutinib
Internal medicine
Refractory CLL
Medicine
safety profile
relapsed refractory
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]